GB2201676B - Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it - Google Patents

Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it

Info

Publication number
GB2201676B
GB2201676B GB8803438A GB8803438A GB2201676B GB 2201676 B GB2201676 B GB 2201676B GB 8803438 A GB8803438 A GB 8803438A GB 8803438 A GB8803438 A GB 8803438A GB 2201676 B GB2201676 B GB 2201676B
Authority
GB
United Kingdom
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
piperazinecarboxylic acid
piperazinecarboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB8803438A
Other versions
GB2201676A (en
GB8803438D0 (en
Inventor
Bernhard Aebischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8803438D0 publication Critical patent/GB8803438D0/en
Publication of GB2201676A publication Critical patent/GB2201676A/en
Application granted granted Critical
Publication of GB2201676B publication Critical patent/GB2201676B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8803438A 1987-02-18 1988-02-15 Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it Expired - Lifetime GB2201676B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878703749A GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid

Publications (3)

Publication Number Publication Date
GB8803438D0 GB8803438D0 (en) 1988-03-16
GB2201676A GB2201676A (en) 1988-09-07
GB2201676B true GB2201676B (en) 1991-01-02

Family

ID=10612501

Family Applications (2)

Application Number Title Priority Date Filing Date
GB878703749A Pending GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid
GB8803438A Expired - Lifetime GB2201676B (en) 1987-02-18 1988-02-15 Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB878703749A Pending GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid

Country Status (28)

Country Link
JP (1) JPH0723387B2 (en)
KR (1) KR960015190B1 (en)
AT (1) AT391320B (en)
AU (1) AU613009B2 (en)
BE (1) BE1002427A3 (en)
CA (1) CA1327799C (en)
CH (1) CH675125A5 (en)
CY (1) CY1739A (en)
DE (1) DE3804936C2 (en)
DK (1) DK168441B1 (en)
ES (2) ES2011319A6 (en)
FI (1) FI86733C (en)
FR (1) FR2610932B1 (en)
GB (2) GB8703749D0 (en)
GR (1) GR1002471B (en)
HK (1) HK142093A (en)
HU (2) HU199858B (en)
IE (1) IE59098B1 (en)
IL (1) IL85436A0 (en)
IT (1) IT1219447B (en)
LU (1) LU87129A1 (en)
MY (1) MY103206A (en)
NL (1) NL8800412A (en)
NZ (1) NZ223529A (en)
PH (1) PH25512A (en)
PT (1) PT86776B (en)
SE (1) SE467256B (en)
ZA (1) ZA881146B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202111B (en) * 1988-03-11 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
EP0488959A3 (en) * 1990-11-28 1992-08-05 Sandoz Ltd. New uses of competitive nmda receptor antagonists
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
US6214604B1 (en) * 1995-05-08 2001-04-10 Lonza Ag Biotechnical production process of piperazine R-α-carboxylic acids and piperazine S-α-carboxylic acid amide
PT984777E (en) 1997-05-12 2004-01-30 Ortho Mcneil Pharm Inc AILOSUBSTITUIDAL PILOTAZINES IN THE TREATMENT OF BENOSTINE PROSTATE HYPERPLASIA
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use
JP2008124531A (en) 2006-11-08 2008-05-29 Nec Electronics Corp Semiconductor device and audio processor chip
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2157685A (en) * 1984-04-17 1985-10-30 Nat Res Dev Piperazine derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2157685A (en) * 1984-04-17 1985-10-30 Nat Res Dev Piperazine derivatives

Also Published As

Publication number Publication date
IT1219447B (en) 1990-05-18
CH675125A5 (en) 1990-08-31
DK79688D0 (en) 1988-02-16
CY1739A (en) 1995-10-20
IL85436A (en) 1992-12-01
GB2201676A (en) 1988-09-07
AT391320B (en) 1990-09-25
KR960015190B1 (en) 1996-11-01
HK142093A (en) 1994-01-07
FI880744A (en) 1988-08-19
NZ223529A (en) 1991-02-26
IE59098B1 (en) 1994-01-12
HUT49361A (en) 1989-09-28
JPS63203691A (en) 1988-08-23
GR880100084A (en) 1988-12-16
AU613009B2 (en) 1991-07-25
GR1002471B (en) 1996-11-15
FI880744A0 (en) 1988-02-17
DK168441B1 (en) 1994-03-28
PH25512A (en) 1991-07-24
LU87129A1 (en) 1988-09-20
PT86776A (en) 1988-03-01
FR2610932A1 (en) 1988-08-19
IT8847631A0 (en) 1988-02-12
FR2610932B1 (en) 1990-11-16
FI86733C (en) 1992-10-12
AU1175888A (en) 1988-08-25
JPH0723387B2 (en) 1995-03-15
BE1002427A3 (en) 1991-02-05
DK79688A (en) 1988-08-19
GB8703749D0 (en) 1987-03-25
DE3804936C2 (en) 1997-02-13
ATA36788A (en) 1990-03-15
CA1327799C (en) 1994-03-15
NL8800412A (en) 1988-09-16
ES2021904A6 (en) 1991-11-16
SE8800541D0 (en) 1988-02-17
GB8803438D0 (en) 1988-03-16
SE8800541A (en) 1988-08-19
FI86733B (en) 1992-06-30
IL85436A0 (en) 1988-07-31
ES2011319A6 (en) 1990-01-01
IE880413L (en) 1988-08-18
SE467256B (en) 1992-06-22
DE3804936A1 (en) 1988-09-01
ZA881146B (en) 1989-10-25
MY103206A (en) 1993-05-29
HU199858B (en) 1990-03-28
PT86776B (en) 1992-05-29
HU211269A9 (en) 1995-11-28
KR880009944A (en) 1988-10-06

Similar Documents

Publication Publication Date Title
IL76453A (en) Isoxazolecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL84723A0 (en) Substituted basic 2-amino-tetralins,their preparation and pharmaceutical compositions containing them
IL81322A0 (en) Thieno-1,4-diazepines,their preparation and pharmaceutical compositions containing them
IL84302A (en) Substituted :-aminoacids, their preparation and pharmaceutical compositions containing them
IL84060A0 (en) Imidazobenzoxazinones,their preparation and pharmaceutical compositions containing them
IL78942A0 (en) Thiazolidinecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL87644A0 (en) Oxadiazolyl-azabicycloheptanes,their preparation and pharmaceutical compositions containing them
IL85969A0 (en) Ribofuranuronic acid derivatives and pharmaceutical compositions containing them
IL83049A (en) 4-quinolinone-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL84808A0 (en) Furanuronic acid derivatives,their preparation and pharmaceutical compositions containing them
GB2201676B (en) Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it
IL86478A (en) Substituted vinylcephalosporins, their preparation and pharmaceutical compositions containing them
IL86926A0 (en) 1h-pyrazole-1-alkanamides,their preparation and pharmaceutical compositions containing them
IL87130A0 (en) Hydrocinnamic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL75913A (en) Phenyl-nonatetraenoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL85612A0 (en) 4-phenylpiperidine compounds,their preparation and pharmaceutical compositions containing them
IL75775A0 (en) Aminoeburnanecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL88743A0 (en) Soluble recombinant fcepsilon-receptor,its preparation and pharmaceutical compositions containing it
IL85824A0 (en) Pyrrolealdehydes,their preparation and pharmaceutical compositions containing them
GB2206115B (en) 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it
IL88673A0 (en) N-hydroxy-5-phenyl-2-furancarboxi-midamides,and pharmaceutical compositions containing them
IL84633A0 (en) 1-aryloxy-3-amino-2-propanols,their preparation and pharmaceutical compositions containing them
IL75776A0 (en) Nitroapovincaminic acid derivatives,their preparation and pharmaceutical compositions containing them
IL81671A0 (en) Substituted pyrimidoindoles,their preparation and pharmaceutical compositions containing them
IL86828A0 (en) Benzo-dipyran derivative,its preparation and pharmaceutical compositions containing it

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee